COHERUS BIOSCIENCES INC (CHRS)

US19249H1032 - Common Stock

2.27  +0.1 (+4.61%)

After market: 2.25 -0.02 (-0.88%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
257.24M211.00M326.60M475.80M356.10M
Minority Interest Expense
N/AN/AN/A0.000.00
Cost Of Goods
158.99M70.10M57.60M37.70M17.10M
Gross Profit
98.25M141.00M269.00M438.20M339.00M
Operating Expenses
296.55M397.80M532.80M281.80M231.20M
Research and Development
105.84M199.40M363.10M142.80M94.20M
Selling, General, and Administrative Expenses
190.72M198.50M169.70M139.10M137.00M
Operating Income
-198.30M-256.90M-263.90M156.30M107.80M
Interest Income/Expense
-40.54M-32.50M-23.00M-21.20M-17.60M
Other Income/Expense
5.47M3.80M-300.00K600.00K2.60M
Non Recurring Items
-4.90M-6.20MN/AN/AN/A
Income Before Taxes
-238.27M-291.80M-287.10M135.70M92.80M
Income Tax
-380.00K0.000.003.50M2.90M
Net Income
-237.89M-291.80M-287.10M132.20M89.80M
EBITDA
-194.51M-253.20M-260.40M159.20M111.10M
 
Per Share Data
EPS Diluted Total Ops
-2.53-3.76-3.811.581.23
Non GAAP EPS
-2.02-3.03-1.151.691.22
 
Statistics
Gross Profit Margin
38.19%66.82%82.36%92.10%95.20%
Profit Margin
-92.48%-138.29%-87.91%27.78%25.22%
Operating Profit Margin
-77.09%-121.75%-80.80%32.85%30.27%

All data in USD

Charts